· Published by Health Canada · Official notice
This is duplicated text of a letter from CareFusion.
Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
September 7, 2010
To Alaris® System users,
Please distribute to relevant Departments: Surgery, Emergency Medicine, Pharmacy, Paediatrics, Anaesthesia, Geriatrics, Internal Medicine, Nursing, Intensive Care, Risk Management, Biomedical Engineering and post this Notice in your institution.
Subject: Alaris PC unit (model 8000) with total bolus display error
Required Action for Users:
Warning Tag: The model 8000 PC unit, when used with an Alaris Pump module or Alaris Syringe module may under certain conditions display an incorrect total dose when programmed to deliver a bolus dose. The Alaris Pump module or Alaris Syringe module delivers the actual programmed bolus dose (and associated volume to be infused) regardless of the displayed total bolus dose.
Follow-up Actions by CareFusion: CareFusion is working to release a software update to address this display error and will contact facilities as soon as the software update is available. CareFusion does not require that you return your devices. Clinicians should weigh the risk/benefits to the patients before continuing the use of the device.
Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any cases of total bolus display error or other serious or unexpected adverse incidents for medical devices in patients using Alaris PC unit model 8000 should be reported to CareFusion or Health Canada at the following addresses:
CareFusion Customer Advocacy:
Phone 888-812-3266 or email: customerfeedback@carefusion.com 24 hours a day, Sunday - Saturday.
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
Health Canada
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate (MHPD)
Email: mhpd_dpsc@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
To change your mailing address or fax number, contact the Market Authorization Holder (Industry).
Sincerely,
original signed by
Michelle J. Badal, RAC
Vice President, Regulatory Affairs, Infusion